News

Semaglutide, available under the brand names Ozempic and Wegovy, may help decrease the risk of major adverse cardiovascular ...
In a retrospective cohort study using propensity matching, among patients with obesity, those taking semaglutide had lower ...
Semaglutide is associated with a high prevalence of adverse events, and its long-term safety is unknown. In an observational ...
The lawsuits come amid several recent studies showing a link between vision complications and people taking drugs ...
Discover how semaglutide reduces heart attack and stroke risk by 20% in overweight individuals, with benefits appearing ...
Online weight-loss company Noom has begun offering smaller doses of compounded versions of Novo Nordisk's Wegovy as the U.S.
Over the past few years, a new class of injectable medications has changed the way obesity is treated. Two drugs—tirzepatide ...
On a weekday morning in Dublin, a group of patients walked into a weight-loss clinic hoping to shed pounds. What they didn’t expect was to also lose their taste for alcohol. A new study has found that ...
Experts say the right diet may offer the same effects as Ozempic by curbing hunger and promoting steady weight loss.
Novo Nordisk (NYSE: NVO) stock jumped 3% through 10:55 a.m. Tuesday on some potentially positive news in the GLP-1 weight ...
A weekly dose of semaglutide, a drug used to manage diabetes and weight loss, was effective in 63% of patients at treating a ...
Today, we're diving into a hot topic in the world of health and wellness: semaglutide. You might have heard about this medication in the context of weight loss. While it's a promising tool, it's ...